Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 118 member A (FAM118A) is a membrane-associated protein whose precise molecular function is not fully characterized but is known to enable identical protein binding and is predicted to be involved in nucleic acid binding[4][1]. It has been identified in the transcriptome of human osteoblasts, where it may influence traits like bone mineral density through a regulatory function, and it is differentially expressed in certain cancers—such as pancreatic adenocarcinoma and glioblastoma stem cells—where it may serve as a prognostic or diagnostic marker[1][6]. FAM118A also appears among molecular signatures distinguishing inflammatory responses in viral infections, supporting its potential utility as a biomarker, although no drugs or therapeutic mechanisms currently target this molecule[1][4]. Its biological roles and mechanisms in disease remain incompletely understood, and it has not been established as a validated therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 118 member A (FAM118A).